This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Dae Hwa Pharma. Co., Ltd.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: The Innovations of Han-Koo Lee
Introduction
Han-Koo Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on developing innovative pharmaceutical compositions for oral administration.
Latest Patents
Han-Koo Lee's latest patents include a pharmaceutical composition for oral administration comprising taxane. This composition includes a taxane, a medium chain triglyceride, an oleoyl glycerol complex, a surfactant, and optionally, a polyoxyl glyceryl fatty acid ester. Another notable patent is a pharmaceutical composition for oral administration comprising a high concentration of taxane. This invention features a specific weight percentage of taxane, medium chain triglyceride, monooleoyl glycerol, surfactant, and polyoxyl glyceryl fatty acid ester.
Career Highlights
Han-Koo Lee is currently associated with Dae Hwa Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing oral drug delivery systems.
Collaborations
Some of his notable coworkers include In-Hyun Lee and Min-Hee Son, who contribute to the collaborative efforts in their research and development projects.
Conclusion
Han-Koo Lee's contributions to pharmaceutical innovations highlight his expertise and commitment to improving drug formulations. His patents reflect a dedication to enhancing oral administration methods, which can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile